721 related articles for article (PubMed ID: 21876081)
21. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
Kim Y; Je Y
Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
[TBL] [Abstract][Full Text] [Related]
23. Associations of the risk of lung cancer with serum 25-hydroxyvitamin D level and dietary vitamin D intake: A dose-response PRISMA meta-analysis.
Wei H; Jing H; Wei Q; Wei G; Heng Z
Medicine (Baltimore); 2018 Sep; 97(37):e12282. PubMed ID: 30212966
[TBL] [Abstract][Full Text] [Related]
24. The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
Feng Y; Cheng G; Wang H; Chen B
Osteoporos Int; 2017 May; 28(5):1641-1652. PubMed ID: 28220196
[TBL] [Abstract][Full Text] [Related]
25. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.
Gorham ED; Garland CF; Garland FC; Grant WB; Mohr SB; Lipkin M; Newmark HL; Giovannucci E; Wei M; Holick MF
Am J Prev Med; 2007 Mar; 32(3):210-6. PubMed ID: 17296473
[TBL] [Abstract][Full Text] [Related]
26. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence.
Jacobs ET; Alberts DS; Benuzillo J; Hollis BW; Thompson PA; Martínez ME
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):752-6. PubMed ID: 17223551
[TBL] [Abstract][Full Text] [Related]
27. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants.
Kunutsor SK; Apekey TA; Steur M
Eur J Epidemiol; 2013 Mar; 28(3):205-21. PubMed ID: 23456138
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
[TBL] [Abstract][Full Text] [Related]
30. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Br J Cancer; 2007 Aug; 97(3):446-51. PubMed ID: 17622244
[TBL] [Abstract][Full Text] [Related]
31. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
32. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk.
Levine AJ; Harper JM; Ervin CM; Chen YH; Harmon E; Xue S; Lee ER; Frankel HD; Haile RW
Nutr Cancer; 2001; 39(1):35-41. PubMed ID: 11588900
[TBL] [Abstract][Full Text] [Related]
33. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
34. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D Intake, Blood 25-Hydroxyvitamin D, and Risk of Ovarian Cancer: A Meta-Analysis of Observational Studies.
Jung S; Jin S; Je Y
J Womens Health (Larchmt); 2023 May; 32(5):561-573. PubMed ID: 36930144
[No Abstract] [Full Text] [Related]
36. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.
Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W
Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829
[TBL] [Abstract][Full Text] [Related]
37. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
[TBL] [Abstract][Full Text] [Related]
38. Nonlinear association between magnesium intake and the risk of colorectal cancer.
Qu X; Jin F; Hao Y; Zhu Z; Li H; Tang T; Dai K
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):309-18. PubMed ID: 23222473
[TBL] [Abstract][Full Text] [Related]
39. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
[TBL] [Abstract][Full Text] [Related]
40. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
